Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

被引:48
|
作者
Rudolph, P
Schubert, C
Schubert, B
Parwaresch, R
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PATHOL,D-2300 KIEL,GERMANY
[2] INST DERMATOPATHOL,BUCHHOLZ,GERMANY
[3] DEPT DERMATOL,BUXTEHUDE,GERMANY
关键词
D O I
10.1016/S0190-9622(97)80121-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A discrimination between benign and malignant melanocytic lesions is not always possible by conventional histology. Objective: Our purpose was to determine the proliferative activity in various types of melanocytic neoplasms and to appraise its value as a diagnostic adjunct. Methods: The growth fraction was assessed immunohistochemically in 398 melanocytic lesions by means of the monoclonal antibody Ki-SS directed to the Ki-67 antigen. In this way, a cut-off level was defined and applied to 112 lesions of equivocal histology. The revised diagnoses were correlated to the clinical courses. Results: Common nevi, Spitz nevi, and melanomas exhibited significantly different proliferation indices and distinctive distribution patterns of cycling cells. In agreement, malignancy diagnosed on the basis of a growth fraction greater than 5% was confirmed by disease progression in 68% of our cases with uncertain diagnosis. Conclusion: Determination of the proliferative activity in melanocytic lesions may usefully complement conventional histology to improve diagnostic accuracy.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 50 条
  • [1] Proliferation marker Ki-S5 is an independent prognostic indicator for neuroblastoma
    Rudolph, P
    Berthold, F
    Parwaresch, R
    Harms, D
    Schmidt, D
    JOURNAL OF PATHOLOGY, 1998, 184 : 10A - 10A
  • [3] Proliferation marker ki-s5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification
    Krams, M
    Hero, B
    Berthold, F
    Parwaresch, R
    Harms, D
    Rudolph, P
    CANCER, 2002, 94 (03) : 854 - 861
  • [4] p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: Possible biopotential markers in human prostatic cancer
    Papadopoulos, I
    Rudolph, P
    Wirth, B
    WeichertJacobsen, K
    UROLOGY, 1996, 48 (02) : 261 - 268
  • [5] PRAME as a Diagnostic Marker in Desmoplastic Melanocytic Lesions: Insights and Challenges
    Ozturk Sari, Sule
    Kolik, Ali Kubilay
    Yeni Erdem, Beguem
    Buyukbabani, Nesimi
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2025, 47 (04) : 334 - 335
  • [6] Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins
    Heidebrecht, HJ
    Buck, F
    Haas, K
    Wacker, HH
    Parwaresch, R
    CELL PROLIFERATION, 1996, 29 (07) : 413 - 425
  • [7] FISH as an effective diagnostic tool for the management of challenging melanocytic lesions
    Mathew W Moore
    Robert Gasparini
    Diagnostic Pathology, 6
  • [8] FISH as an effective diagnostic tool for the management of challenging melanocytic lesions
    Moore, Mathew W.
    Gasparini, Robert
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [9] The relationship between the proliferation marker Ki67 and the grading of atypia in melanocytic nevi
    Arumi-Uria, M
    Reed, JA
    Finnerty, B
    McNutt, NS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 54A - 54A
  • [10] Expression of CD95 ligand in melanocytic lesions as a diagnostic marker
    Maeda, A
    Aragane, Y
    Tezuka, T
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (02) : 198 - 206